By Drug Target Review2025-10-27T15:46:17
Cellarity has published a new paper in detailing an AI-powered framework that integrates single-cell transcriptomics to make drug discovery faster and more successful.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-02-03T13:56:13
Sponsored by Leica Microsystems
2023-02-16T14:53:10
Sponsored by Cell Signaling Technology
2023-02-02T11:05:15
Sponsored by Cell Signaling Technology
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa
2023-07-04T10:05:58
Sponsored by Revvity
2023-07-11T16:13:06
Sponsored by Agilent
Site powered by Webvision Cloud